Drug Profile
Lasmiditan - Eli Lilly and Company
Alternative Names: COL-144; LY-573144; Rayvow; REYVOWLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Eli Lilly and Company; Lundbeck A/S
- Developer Eli Lilly and Company; Ildong Pharmaceutical
- Class Antimigraines; Benzamides; Fluorinated hydrocarbons; Piperidines; Pyridines; Small molecules
- Mechanism of Action Serotonin 1F receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Migraine